论文信息 - Efficacy of Pirtobrutinib in Covalent BTK-Inhibitor Pre-Treated Relapsed / Refractory Mantle Cell Lymphoma: Additional Patients and Extended Follow-up from the Phase 1/2 BRUIN Study - 字舞流文

Efficacy of Pirtobrutinib in Covalent BTK-Inhibitor Pre-Treated Relapsed / Refractory Mantle Cell Lymphoma: Additional Patients and Extended Follow-up from the Phase 1/2 BRUIN Study

A. Alencar | A. Zelenetz | I. Flinn | P. Zinzani | P. Jain | F. Hernandez-Ilizaliturri | R. Walgren | C. Tam | K. Izutsu | B. Nair | C. Cheah | H. Nagai | A. Mato | Yucai Wang | J. Seymour | M. Balbas | Anita Kumar | C. Ujjani | E. Lech-Maranda | W. Jurczak | Chunxiao Wang | T. Munir | T. Eyre | N. Shah | J. Woyach | N. Lamanna | P. Abada | J. Gerson | B. Tessoulin | Youngil Koh | K. Patel | Joanna M. Rhodes | D. E. Tsai | Michael L. Wang | Shuo Ma | Junjie Zhao | Y. Koh | Talha Munir